Discordantly normal ApoB relative to elevated LDL-C in persons with metabolic disorders: A marker of atherogenic heterogeneity

• Main Authors: Alexander C. Razavi (Author), Lydia A. Bazzano (Author), Jiang He (Author), Marie Krousel-Wood (Author), Kirsten S. Dorans (Author), Michael A. Razavi (Author), Camilo Fernandez (Author), Seamus P. Whelton (Author), Tanika N. Kelly (Author)
• Format: Book
• Published: Elsevier, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: A significant proportion of persons with metabolic syndrome (MetS), prediabetes, or type 2 diabetes (T2D) do not develop atherosclerotic cardiovascular disease (ASCVD).We sought to determine whether discordantly normal apolipoprotein B (ApoB) relative to elevated LDL-C may help to explain...